• Real Cardiology: Chuck Simonton Interview

    Dr. Waksman and Dr. Simonton (Abbott Vascular – CMO) discussing the commercialization of bioresorbable stents (BRS) in the US. Investigator/clinician and industry leadership perspective.

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details